Timothy J Stuhlmiller

3PUBLICATIONS
27CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 05, 2025
Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma.

Smita Matkar, Michael P East, Timothy J Stuhlmiller

|Apr 18, 2024
An atlas of causal and mechanistic drivers of interpatient heterogeneity in glioma.

Serdar Turkarslan, Yu He, Parvinder Hothi

Pageof 1